Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Medivir’s CEO: “There is an obvious need for fostrox”

Medivir has gone through an eventful period, marked by the presentation of clinical results at ESMO and a new collaboration agreement with pharmaceutical giant Eisai. The next target is a randomized phase IIb study to enable breakthrough therapy designation and accelerated approval process. CEO Jens Lindberg notes that these recent developments have strengthened fostrox’s potential to become the first approved treatment for second-line liver cancer.Read the article at biostock.se: https://www.biostock.se/en/2024/11/medivirs-ceo-there-is-an-obvious-need-for-fostrox/ This is a press

Telia announces tender offer and proposal in respect of certain outstanding GBP notes

Not for distribution, directly or indirectly, in or into or to any person located or resident in the United States, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands), any state of the United States or the District of Columbia or to any U.S. Person (as defined in Regulation S under the U.S. Securities Act of 1933, as amended) or in or into any other jurisdiction where it is unlawful to distribute this announcement. Telia Company AB (“Telia”) has today announced separate invitations to: (i)

A Festive Journey of Flavours: Experience Finnish Christmas in Helsinki

Photo: Jussi Hellsten, Torikorttelit This winter, Helsinki invites you to indulge in the tastes, traditions and treats of a Finnish Christmas. During the month leading up to the holidays, the city transforms into a winter wonderland where markets, festive events and Christmas lunches celebrate the Finnish capital’s vibrant food culture. As December approaches, Christmas magic finds itself into Helsinki’s restaurants, delis and market squares. It’s the cozy season and Finns know how to make the most of it, lighting up dark evenings with twinkling lights, gathering for long,

Immedica welcomes Benjamin Owens as Head of Corporate Development

Stockholm, November 11, 2024 – Immedica is pleased to announce that Benjamin Owens, Ph.D. has joined the company as Executive Vice President and Head of Corporate Development. Ben brings 15 years of experience in the life sciences field including roles in business development and operational leadership across both R&D- and commercial-stage companies. Benjamin has a track record of successfully sourcing, leading and executing strategic transactions, including M&A, cross-border licensing, financing and company formation. With broad expertise in areas ranging from R&D,  clinical development

Repurchase of Truecaller B shares in week 45, 2024

During 4 November 2024 and 8 November 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 50,000 own B shares (ISIN: SE0016787071), corresponding to 0.01% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the programme, in the end of May, almost 3.7 million B-shares has been repurchased which corresponds to 1.04% of the outstanding capital.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up

Qlife announces outcome in directed issues

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN, HONG KONG, SOUTH KOREA, SINGAPORE, SOUTH AFRICA, SWITZERLAND, RUSSIA OR BELARUS OR ANY OTHER STATE OR JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Qlife Holding AB (publ) (”Qlife” or the ”Company”) announces the outcome of the directed issues of shares and warrants to Warthoe Af 1967 ApS (owned by Thomas Warthoe, CEO), Altia Invest ApS (

Smoltek Hydrogen participates in the Scandinavian delegation for meetings with the German hydrogen industry

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek (“Smoltek” or “the Company”) announces that the subsidiary Smoltek Hydrogen has been invited to participate in a Scandinavian delegation of technology leading hydrogen companies for a round-trip to Germany’s energy-producing regions in Rhur and central Germany. This is an excellent opportunity to network with the German hydrogen industry and talk about Smoltek Hydrogen's low iridium porous transport electrode (PTE) for PEM electrolyzers.Between 11 and 13

The exercise period for CLS warrants of series TO 7 begins today

In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrants of series TO 7 B (the “Rights Issue”). The exercise period for the warrants begins today, November 11, 2024 and runs up to and including November 22, 2024. One (1) warrant entitle the holder to subscribe for one (1) new B-share in CLS. The subscription price per B-share that is subscribed for through exercising the warrants has, in accordance with the terms and conditions for the warrants, been set to SEK 3.68. If all warrants are exercised, CLS will receive

Aquaporin secures milestone contract in Central Asia

Aquaporin is pleased to announce a significant order for a municipal drinking water treatment plant project in Central Asia. This project marks the, to date, largest individual order of our innovative CLEAR elements, with a treatment capacity of 25,000 cubic meters per day. The customer, a leading Engineering, Procurement, and Construction (EPC) company based in the Central Asia region, has chosen Aquaporin’s advanced water treatment solutions to enhance the quality and availability of the water from the municipal drinking water treatment plant. At Aquaporin, we are happy to

David Ruggiero Join Sinch as Senior Vice President of Sales

Appointment Aims to Drive Growth and Strengthen Customer Relationships in North AmericaATLANTA, Georgia and STOCKHOLM, Sweden – November 11, 2024 – Sinch  (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is pleased to announce the appointment of David Ruggiero as Senior Vice President of Sales for the North America region.  A highly experienced executive with over 25 years of expertise in sales leadership across Enterprise, Mid Markets and SMB, David will lead Sinch’s sales strategy in the

Telia Towers Norway chooses iLOQ smart locks to enhance security

iLOQ has signed a ground-breaking agreement with Telia Towers Norway for the deployment of its innovative battery-free and keyless smart-locking system across the company’s more than 1000 tower sites. The rollout of iLOQ’s advanced locking system has already commenced, with a goal to replace Telia Towers’ existing locks throughout their footprint in Norway over the next two years. The existing locks can be quickly and easily replaced with iLOQ’s smart locks with no changes to the existing infrastructure needed. iLOQ’s technology will enhance both convenience and security by

Cary Group strengthens the management team

Cary Group, a European market leader in vehicle glass repair and replacement, has appointed Lars Egelstig as new CFO. At the same time, Joakim Rasiwala, the company's current CFO, will transfer to the role as Head of M&A and Integration.Lars Egelstig, who takes up his role as CFO of Cary Group today, November 11th, comes most recently from the role of CFO at Nordomatic. Joakim Rasiwala, current CFO at Cary Group, will gradually transition to the new role of Head of M&A and Integration during the remainder of 2024. The role means that Joakim will be responsible for Cary Group's Mergers &

SSAB at COP29: Time to commit to ambitious climate plans to drive the transition forward

SSAB is joining Business Sweden’s delegation to the United Nations Climate Change Conference, COP29 in Baku, Azerbaijan. Our hope is that countries increase their national ambitions to limit climate change and to create enabling conditions for investments and a competitive transformation. SSAB will describe our journey to near zero-emission steelmaking as a way of exemplifying what breakthrough technologies are available to decarbonize the steel industry. Last year’s COP marked a moment of progress as the need to transition away from fossil fuels was mentioned for the first time

Celebrating excellence in emerging markets: East Capital Awards 2024 honours Optima Bank, Gravita, FPT Corporation, and Qifu Technology

For over two decades, East Capital has celebrated companies within its investment portfolio that drive positive change. The prestigious East Capital Awards highlight those organizations that stand out for their growth, governance, and pioneering achievements. In 2024, the Awards reflect the remarkable geographical spread and strength of East Capital’s emerging market’s universe, spanning Greece, India, Vietnam, and China. We are proud to announce this year’s winners across four categories: Best IPO, Discovery of the Year, Best Growth, and Best Corporate Governance.· Optima Bank – Best IPO

Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the treatment of peritoneal carcinomatoses. The studies were closed for recruitment at the end of 2023, and patients are currently in long-term follow-up. The readout confirmed the previously published results on efficacy and adds further confidence in the ongoing randomized controlled Phase 2 clinical trial for Radspherin® in patients with ovarian cancer.In the first interim readout from the Phase 1

Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024

Episurf Medical (Nasdaq: EPIS B) will attend Redeye Medtech & Diagnostics Event which is held on November 13th, 2024. The event is arranged by Redeye and the company will be represented by its CEO Pål Ryfors. The format will be a 12-minute presentation followed by an 8-minute Q&A Session. The presentation will be streamed live at 09:50 CET at https://www.redeye.se/events/1016182/redeye-theme-medtech-diagnostics-3 and will also be made available afterwards on our website www.episurf.com. If you would like to attend the event in person, you can register at https://crm.redeye.se/events/

Interim report Q3, 2024

Third quarter · Net sales amounted to SEK 1.9 (3.9*) million · EBITDA amounted to SEK -1.8 (-2.2) million · EBIT amounted to SEK -8.5 (-18.0) million · EBT amounted to SEK -10.3 (-18.8) million - Change of Certified Adviser (CA) to Bergs Securities *including revenues from the now divested company BizWell Sweden AB  Dear Valued Shareholders, I hope this message finds you well. As we reflect on the third quarter, it’s important to acknowledge that our financial results fell short of expectations, especially compared to the same period last year. Despite these

TF Bank: Monthly statistics October 2024

The total loan portfolio amounted to SEK 21,159 million at the end of October. Compared to October 2023, the loan portfolio has increased by 20 % in local currencies.  Month Oct-24 Oct-23 ChangeCredit Cards   New lending, SEK million 1,560 1,051 48 %Ecommerce Solutions   Transaction volume*, SEK million 1,290 1,386 -7 %Consumer Lending   New lending, SEK million 476 279 71 %  Cumulative for the year Jan-Oct 24 Jan-Oct 23 ChangeCredit Cards   New lending, SEK million 13,

Finnish Nurminen Logistics Plc acquires Swedish railway logistics company Essinge Rail AB and grows into a significant Nordic railway operator

Nurminen Logistics Plc      Press release 11 November 2024 at 9.15 a.m. EET  Finnish logistics company, Nurminen Logistics Plc, acquires the Swedish railway logistics company Essinge Rail AB. With the acquisition, Nurminen Logistics will grow into a significant railway operator in the growing freight traffic between the Nordic countries and Continental Europe, serving Nordic and international companies in the industrial, technology and commercial sectors. The acquisition is part of Nurminen Logistics' profitable internationalization and growth strategy, which significantly expands the

Suomen Lantakaasu investing more than EUR 80 million in Kiuruvesi biogas plant project

Suomen Lantakaasu Oy’s biogas plant to be constructed in Kiuruvesi, Finland will produce renewable liquefied biogas from cattle farm manure in Upper Savo and from other agricultural and food industry byproducts. The investment covers the construction of the biogas plant and the liquefaction unit. The preparatory groundwork phase has already been finalized and construction of the biogas plant will begin this winter. The plant will be completed in 2026.The Kiuruvesi biogas plant is part of the Upper Savo complex that includes the industrial-scale, centralised liquefied biogas production plant

Inside information: Nurminen Logistics Plc acquires Swedish railway logistics company Essinge Rail AB and grows in rail logistics between the Nordic countries and Continental Europe

Nurminen Logistics Plc    Stock Exchange Release (Inside information)     11 November 2024 at 09.00 a.m. EET  Nurminen Logistics Plc has signed an agreement to acquire the entire share capital of the Swedish Essinge Rail AB. With the acquisition, Nurminen Logistics Plc will become a significant railway operator in the growing freight traffic between the Nordic countries and Continental Europe, serving Nordic and international companies in the industrial, technology and commercial sectors. The acquisition is part of Nurminen Logistics' international growth strategy, which focuses on

The subscription period in Spermosens’ rights issue of units begins today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE   Today, 11 November 2024, is the first day of the subscription period in Spermosens AB:s (publ) (“Spermosens” or the “Company”) issue of a maximum of 283,607,120 units, corresponding to a maximum of 2,268,856,960 shares,

Nomination Committee appointed for Bactiguard Holding AB’s Annual General Meeting 2025

The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Thursday 15 May 2025 in Stockholm, has been appointed. The Nomination Committee will consist of: · Helena Borglund (appointed by TomBact AB) · Christian Kinch (appointed by GIDL Invest AB) · Jan Ståhlberg (appointed by Jan Ståhlberg) · Mats J Andersson (appointed by Nordea Fonder) · Jannis Kitsakis (appointed by Fjärde AP Fonden) In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of

There are no items matching the current filter
There are no more items matching the current filter
Back to top